EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Respiratory Syncytial Virus Vaccine Design Using Structure-Based Machine-Learning Models

Thomas C McCarty iD, Iosif I Vaisman iD

Viruses · 2024

DOI: 10.3390/v16060821 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Thomas C McCarty und 1 weiteren Autor:innen. Beteiligte Einrichtung: RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health …. Hauptthemen laut MEDLINE: Machine Learning, Viral Nonstructural Proteins, Respiratory Syncytial Virus Vaccines, Respiratory Syncytial Virus, Human. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), NIAID NIH HHS, Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

When designing live-attenuated respiratory syncytial virus (RSV) vaccine candidates, attenuating mutations can be developed through biologic selection or reverse-genetic manipulation and may include point mutations, codon and gene deletions, and genome rearrangements. Attenuation typically involves the reduction in virus replication, due to direct effects on viral structural and replicative machinery or viral factors that antagonize host defense or cause disease. However, attenuation must balance reduced replication and immunogenic antigen expression. In the present study, we explored a new approach in order to discover attenuating mutations. Specifically, we used protein structure modeling and computational methods to identify amino acid substitutions in the RSV nonstructural protein 1 (NS1) predicted to cause various levels of structural perturbation. Twelve different mutations predicted to alter the NS1 protein structure were introduced into infectious virus and analyzed in cell culture for effects on viral mRNA and protein expression, interferon and cytokine expression, and caspase activation. We found the use of structure-based machine learning to predict amino acid substitutions that reduce the thermodynamic stability of NS1 resulted in various levels of loss of NS1 function, exemplified by effects including reduced multi-cycle viral replication in cells competent for type I interferon, reduced expression of viral mRNAs and proteins, and increased interferon and apoptosis responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Machine LearningViral Nonstructural ProteinsRespiratory Syncytial Virus VaccinesRespiratory Syncytial Virus, HumanVirus ReplicationHumansVaccines, AttenuatedRespiratory Syncytial Virus InfectionsAmino Acid SubstitutionMutationCell Line

Stichwörter der Autor:innen

NS1computational analysis of viral protein structurecomputational mutagenesisinterferon antagonistlive-attenuated virus vaccine designmachine learningmutational analysis of interferon antagonistnegative-strand RNA virusnonstructural protein 1respiratory syncytial virusviral protein structure modification

Substanzen

Viral Nonstructural ProteinsRespiratory Syncytial Virus VaccinesVaccines, Attenuated

Autor:innen und Institutionen

  • RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA.
  • School of Systems Biology, George Mason University, Manassas, VA 20110, USA.

ORCID-Profile: Thomas C McCarty, Iosif I Vaisman

Förderung

  • the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)
  • NIAID NIH HHS
  • Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID)
  • National Institutes of Health (NIH)

Zitieren

APA

McCarty, T. C., & Vaisman, I. I. (2024). Respiratory Syncytial Virus Vaccine Design Using Structure-Based Machine-Learning Models. Viruses. https://doi.org/10.3390/v16060821

Vancouver

McCarty TC, Vaisman II. Respiratory Syncytial Virus Vaccine Design Using Structure-Based Machine-Learning Models. Viruses. 2024. doi:10.3390/v16060821

BibTeX
@article{McCarty2024,
  author = {McCarty, Thomas C and Vaisman, Iosif I},
  title = {Respiratory Syncytial Virus Vaccine Design Using Structure-Based Machine-Learning Models},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16060821}
}
Kostenlos starten →